Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015 Dec;41(12):2138-48.
doi: 10.1007/s00134-015-3979-7. Epub 2015 Aug 13.

Predictive value for weakness and 1-year mortality of screening electrophysiology tests in the ICU

Greet Hermans  1   2 , Helena Van Mechelen  3 , Frans Bruyninckx  4 , Tine Vanhullebusch  3 , Beatrix Clerckx  5 , Philippe Meersseman  6 , Yves Debaveye  3   5 , Michael P Casaer  3   5 , Alexander Wilmer  6 , Pieter J Wouters  3   5 , Ilse Vanhorebeek  3 , Rik Gosselink  7 , Greet Van den Berghe  3   5
Affiliations
Randomized Controlled Trial

Predictive value for weakness and 1-year mortality of screening electrophysiology tests in the ICU

Greet Hermans et al. Intensive Care Med. 2015 Dec.

Abstract

Purpose: Muscle weakness in long-stay ICU patients contributes to 1-year mortality. Whether electrophysiological screening is an alternative diagnostic tool in unconscious/uncooperative patients remains unknown. We aimed to determine the diagnostic properties of abnormal compound muscle action potential (CMAP), sensory nerve action potential (SNAP), and spontaneous electrical activity (SEA) for Medical Research Council (MRC)-defined weakness and their predictive value for 1-year mortality.

Methods: Data were prospectively collected during the EPaNIC trial (ClinicalTrials.gov: NCT00512122). First, sensitivity, specificity, positive (PPV) and negative predictive values (NPV) of abnormal CMAP, SNAP, and SEA for weakness were determined. Subsequently, association between 1-year mortality and abnormal findings on electrophysiological screening was assessed by univariate and multivariate analyses correcting for weakness and other risk factors and the prediction model involved only a development phase.

Results: A total of 730 patients were electrophysiologically screened of whom 432 were tested for weakness. On day 8, normal CMAP excluded weakness with a high NPV (80.5 %). By day 15, abnormal SNAP and the presence of SEA had a high PPV (91.7 and 80.0 %, respectively). Only a reduced CMAP on day 8 was associated with higher 1-year mortality [35.6 vs 15.2 % (p < 0.001)]. This association remained significant after correction for weakness and other risk factors [OR 2.463 (95 % CI 1.113-5.452), p = 0.026]. Also among conscious/cooperative patients without weakness, reduced CMAP was independently associated with a higher likelihood of death occurring during 1 year [HR 2.818 (95 % CI 1.074-7.391), p = 0.035].

Conclusions: The diagnostic properties of electrophysiological screening vary over time. Abnormal CMAP documented early during critical illness carries information about longer-term outcome, which should be further investigated mechanistically.

Keywords: Electrophysiology; Intensive care; Mortality; Muscle weakness.

PubMed Disclaimer

Comment in

References

    1. Intensive Care Med. 2014 May;40(5):746-8 - PubMed
    1. N Engl J Med. 2014 Apr 24;370(17):1626-35 - PubMed
    1. Intensive Care Med. 2000 Sep;26(9):1360-3 - PubMed
    1. Intensive Care Med. 2003 Sep;29(9):1505-14 - PubMed
    1. JAMA. 1995 Oct 18;274(15):1221-5 - PubMed

Publication types

Associated data

LinkOut - more resources